Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Immunosuppression Only Conditioning -Closed with amendment L
Reduced Intensity Conditioning
+3 more
Locations
2
United States
National Institutes of Health Clinical Center
Bethesda, Maryland, United States
National Marrow Donor Program
Minneapolis, Minnesota, United States
Start Date
November 19, 2015
Primary Completion Date
December 31, 2031
Completion Date
December 31, 2036
Last Updated
April 24, 2026
NCT06575426
NCT07284641
NCT06069583
NCT06173544
NCT06271252
NCT03602157
Lead Sponsor
National Cancer Institute (NCI)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions